B. Riley Issues Negative Estimate for Novavax Earnings
B. Riley cut their Q1 2025 earnings per share estimates for Novavax in a report issued on Monday, March 3rd. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will post ...
TipRanks on MSN23h
Novavax (NVAX) Predicts Profitability by 2027 Despite Recent Stock Drop
Novavax ($NVAX) has recently seen a decrease in stock value, dropping after announcing Q4 results that missed revenue ...
MarketWatch15h
Novavax Inc.
Inovio Pharmaceuticals Inc. 2.06% $71.48M ...
FDA chief nominee Makary pledges to 'review' cancellation of vaccine panel meeting
FDA nominee Marty Makary pledges to review the cancellation of a key flu vaccine meeting, addressing concerns over ...